Rivaroxaban Xarelto 15 mg Tablets About
Rivaroxaban Xarelto 15 mg Tablets, a praiseworthy oral anticoagulant, deliver flawless performance in cardiovascular care. Engineered in Germany and regulatory-approved in major global markets, these film-coated tablets offer a cost-effective solution for the prevention and treatment of DVT, PE, and stroke risk in non-valvular atrial fibrillation. Each redoubtable blister-packed box includes 28 tablets, ensuring reliable value for prescribed patients. Prior consultation with a healthcare provider is imperative. Store below 30C to preserve therapeutic integrity. Prescription required.
Usage & Applications for Rivaroxaban Xarelto 15 mg Tablets
Propelled by its redoubtable efficacy, Rivaroxaban Xarelto 15 mg Tablets are chiefly used in anticoagulation therapy. Administered orally, they are intended for adults at risk of stroke, deep vein thrombosis, or pulmonary embolism. This value-driven option is applied via the oral route, acting systemically within the circulation. As prescribed by a physician, the tablets are recommended for individuals requiring precise and flaw-free management of blood clot risks due to specific cardiovascular conditions.
Packaging Details and Sample Policy for Rivaroxaban Xarelto 15 mg Tablets
Each flawless batch is meticulously packaged in a blister pack, enclosed within a boxed set containing 28 tablets. The outlay ensures protection from moisture and sunlight, safeguarding potency across domestic mar. Sample availability depends on the trader's policy; interested professionals are invited to handover queries regarding samples or full product acquisition. Transparent sample policy details and assistance are provided upon request, ensuring efficiency and praiseworthy support through every step-from inquiry to delivery.
FAQ's of Rivaroxaban Xarelto 15 mg Tablets:
Q: How is Rivaroxaban Xarelto 15 mg Tablet administered?
A: Rivaroxaban Xarelto 15 mg is administered orally as prescribed by your healthcare professional, typically once daily with food, unless otherwise directed.
Q: What is the main benefit of using Rivaroxaban Xarelto 15 mg Tablets?
A: The primary benefit includes flawless prevention of stroke, deep vein thrombosis, and pulmonary embolism in adults with relevant cardiovascular conditions, aiding in the reduction of potentially life-threatening events.
Q: When should patients avoid taking Rivaroxaban Xarelto 15 mg Tablets?
A: Patients with active bleeding, severe renal impairment, or hypersensitivity to rivaroxaban should avoid this medication. Medical advice must be sought before initiating therapy.
Q: Where can I find approved Rivaroxaban Xarelto 15 mg Tablets?
A: This prescription-only medicine is approved and available in Canada, the EU, UK, USA, Australia, and India through authorized manufacturers, suppliers, and traders.
Q: What precautions are necessary during the use of Rivaroxaban Xarelto 15 mg Tablets?
A: Consult your healthcare provider before use, closely follow prescribed dosage instructions, and store tablets below 30C, protected from moisture and sunlight.
Q: How does Rivaroxaban Xarelto 15 mg support anticoagulation therapy?
A: It acts as a blood thinner, effectively reducing the clotting ability of the blood and hence lowering the risk of stroke or systemic embolism in susceptible individuals.